Cygenia

Cygenia Epigenetic biomarkers and diagnostics Cygenia GmbH is an innovative young company in the field of epigenetics, founded in March 2014 in Aachen, Germany.

We established methods for epigenetic biomarkers which are continuously developed and are of interest to scientists and clinicians. It is the first company to provide this kind of service on epigenetic biomarkers. Our close cooperation with Varionostic GmbH – the Europe’s leading expert for DNA methylation analysis - guarantees high quality for DNA methylation analysis.

26/06/2017

We are looking forward to meet you at our booth at the 5th Annual German Stem Cell Network (GSCN) Conference in Jena from 11 - 13 September 2017.
http://www.gscn.org/Conferences/2017/HOME.aspx

Web page of the 5th Annual GSCN Conference from 11 - 13 September 2017 at Friedrich Schiller University (FSU) Jena

Check out this recent article on "    clocks in mice and men" by Wolfgang Wagner.https://www.ncbi.nlm.nih.gov/pmc/articl...
26/06/2017

Check out this recent article on " clocks in mice and men" by Wolfgang Wagner.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470213/pdf/13059_2017_Article_1245.pdf

06/02/2017

Further progress in the development of epigenetic biomarkers for age prediction: we found individual CpG sites that are strongly associated with age and life expectancy and which are hypomethylated upon aging
https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-017-0315-9

There is a growing interest in simple molecular biomarkers for biological aging. Age-associated DNA methylation (DNAm) changes at specific CG dinucleotides can be combined into epigenetic age predictors to estimate chronological age—and the deviation of chronological and predicted age (∆age) seems t...

We are looking forward to meet you at our booth at the 9th International Meeting of the Stem Cell Network NRW in Münster...
27/01/2017

We are looking forward to meet you at our booth at the 9th International Meeting of the Stem Cell Network NRW in Münster from 16th-17th May.
http://www.kongress.stammzellen.nrw.de

Finally! We are happy to introduce you our improved web page: www.cygenia.comFind all of our     at one place and enjoy ...
11/10/2016

Finally! We are happy to introduce you our improved web page: www.cygenia.com
Find all of our at one place and enjoy the user-friendly design and better functionality!

Your Cygenia Team.

  is a disease of premature aging and is associated with impaired   maintenance and with clinical features of premature ...
22/04/2016

is a disease of premature aging and is associated with impaired maintenance and with clinical
features of premature aging. So far, diagnosis of relies particularly on telomere length measurements, but not all patients reveal significant telomere attrition raising the need for additional biomarkers.

Our latest is associated with aberrant DNA-methylation in PRDM8. Along with traditional methods it enables the identification of patients with normal telomere length.

Find out more at www.cygenia.com!

DNA methylation in PRDM8 is indicative for dyskeratosis congenita

Our epigenetic age predictors based on 99 CpGs, 3 CpGs, or individual CpGs correlate with all-cause mortality.          ...
22/04/2016

Our epigenetic age predictors based on 99 CpGs, 3 CpGs, or individual CpGs correlate with all-cause mortality.

AGING Journal

Cygenia wishes you happy easter holidays! :)
26/03/2016

Cygenia wishes you happy easter holidays! :)

We offer two new biomarkers to classify human mesenchymal stem cells (MSCs): - Epi-MSC-Score- Epi-Tissue-Score          ...
10/02/2016

We offer two new biomarkers to classify human mesenchymal stem cells (MSCs):
- Epi-MSC-Score
- Epi-Tissue-Score

DNA methylation profiles (generated on Illumina HumanMethylation BeadChips 27K or 450K) were stratified by cell type (MSCs versus fibroblasts), tissue source (here particularly MSCs from bone marrow versus adipose tissue), passage (P5), age (40 years), and serum supplements in cultur…

We have a new prognostic biomarker for acute myeloid leukemia patients
10/02/2016

We have a new prognostic biomarker for acute myeloid leukemia patients

An "epimutation" can mimic genomic mutations in DNMT3A - a biomarker for acute myeloid leukemia
10/02/2016

An "epimutation" can mimic genomic mutations in DNMT3A - a biomarker for acute myeloid leukemia

Do you really have iPS cells? Confirm pluripotency with our Epi-Pluri-Score
10/02/2016

Do you really have iPS cells? Confirm pluripotency with our Epi-Pluri-Score

Quality control of human induced pluripotent stem cells (iPSCs) can be performed by several methods. These methods are usually relatively labor-intensive, difficult to standardize, or they do not facilitate reliable quantification.

Adresse

Franz-Wallraff Strasse 158
Aachen
52078

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Cygenia erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an Cygenia senden:

Teilen